Involvement of SH2-SH2-SH3 domain of phospholipase Cγ1 in NF-κB signaling

FEBS Letters

Volumn 472, Issue 1, 2000, Pages 45-49

  Kim, Bo Yeon ^a   Kang, Dae Ook ^a   Oh, Won Keun ^a   Kim, Jin Hee ^a   Choi, Yong Kyung ^a   Jang, Jong Soo ^b   Suh, Pann Ghill ^c   Ryu, Sung Ho ^c   Mheen, Tae Ick ^a   Ahn, Jong Seog ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Daejin University   (South Korea)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Mitogen activated protein kinase; Nuclear factor B; Phosphatidylinositol 3 kinase; Phospholipase C 1; Protein kinase C; SH2 SH3

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; GENISTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; TYRPHOSTIN; WORTMANNIN;

ARTICLE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYDROLYSIS; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN DOMAIN; REPORTER GENE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

3T3 CELLS; ANIMALS; CELL LINE; GENES, REPORTER; ISOENZYMES; LUCIFERASES; MICE; NF-KAPPA B; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA; RATS; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; TRANSFECTION;

EID: 0034696961     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(00)01415-0     Document Type: Article

References (27)

1. Baldwin A.S. Jr. Annu. Rev. Immunol. 14:1996;649-683.
2. Liou H.C., Baltimore D. Curr. Opin. Cell Biol. 5:1993;477-487.
3. Thanos D., Maniatis T. Cell. 80:1995;529-532.
4. Verma I.M., Stevenson J.K., Schwarz E.M., Van Antwerp D., Miyamoto S. Genes Dev. 9:1995;2723-2735.
5. Baeuerle P.A., Baltimore D. Cell. 87:1996;13-20.
6. Beraud C., Henzel W.J., Baeuerle P.A. Proc. Natl. Acad. Sci. USA. 96:1999;429-434.
7. Abu-Amer Y., Ross F.P., McHugh K.P., Livolsi A., Peyron J.F., Teitelbaum S.L. J. Biol. Chem. 273:1998;29417-29423.
8. Yamamoto H., Hanada K., Nishijima M. Biochem. J. 325:1997;223-228.
9. Wahl M., Carpenter G. Bioessays. 13:1991;107-113.
10. Emori Y., Homma Y., Sorimachi H., Kawasaki H., Nakanishi O., Suzuki K., Takenawa T. J. Biol. Chem. 264:1989;21885-21890.
11. Chang J.S., Noh D.Y., Park I.A., Kim M.J., Song H., Ryu S.H., Suh P.G. Cancer Res. 57:1997;5465-5468.
12. Bergmann M., Hart L., Lindsay M., Barnes P.J., Newton R. J. Biol. Chem. 273:1998;6607-6610.
13. Cobb R.R., Felts K.A., Parry G.C., Mackman N. Mol. Pharmacol. 49:1996;998-1004.
14. Janssen Y.M., Sen C.K. Methods Enzymol. 300:1999;363-374.
15. Kim B.Y., et al. Biochim. Biophys. Acta. 1311:1996;33-36.
16. Kim B.Y., Ahn S.C., Oh H.K., Lee H.S., Mheen T.I., Rho H.M., Ahn J.S. Biochem. Biophys. Res. Commun. 212:1995;1061-1067.
17. Lee Y.H., Kim H.S., Pai J.K., Ryu S.H., Suh P.G. J. Biol. Chem. 269:1994;26842-26847.
18. Yeo E.J., Kazlauskas A., Exton J.H. J. Biol. Chem. 269:1994;27823-27826.
19. Jin W., Lo T.M., Loh H.H., Thayer S.A. Brain Res. 642:1994;237-243.
20. Lockhart L.K., McNicol A. J. Pharmacol. Exp. Ther. 289:1999;721-728.
21. Partik G., Hochegger K., Schorkhuber M., Marian B. J. Cancer Res. Clin. Oncol. 125:1999;379-388.
22. Song H.Y., Regnier C.H., Kirschning C.J., Goeddel D.V., Rothe M. Proc. Natl. Acad. Sci. USA. 94:1997;9792-9796.
23. Diaz-Meco M.T., et al. EMBO J. 13:1994;2842-2848.
24. Genot E.M., Parker P.J., Cantrell D.A. J. Biol. Chem. 270:1995;9833-9839.
25. Janosch P., et al. J. Biol. Chem. 271:1996;13868-13874.
26. Tapon N., Nagata K., Lamarche N., Hall A. EMBO J. 17:1998;1395-1404.
27. Hohashi N., Hayashi T., Fusaki N., Takeuchi M., Higurashi M., Okamoto T., Semba K., Yamamoto T. Int. Immunol. 7:1995;1851-1859.